The business of RNAi therapeutics
Hum Gene Ther
.
2008 May;19(5):451-62.
doi: 10.1089/hum.2008.007.
Author
Dirk Haussecker
1
Affiliation
1
Department of Pediatrics, Stanford School of Medicine, Stanford, CA 94305, USA. dirkh@stanford.edu
PMID:
18435603
DOI:
10.1089/hum.2008.007
No abstract available
Publication types
Review
MeSH terms
Biotechnology / economics
Biotechnology / trends*
Commerce / economics
Commerce / trends*
Drug Industry / economics
Drug Industry / trends*
Humans
RNA Interference*
RNA, Small Interfering / therapeutic use*
Risk
Substances
RNA, Small Interfering
Grants and funding
R01 AI071068/AI/NIAID NIH HHS/United States
R01 DK078424/DK/NIDDK NIH HHS/United States
R37 AI071068/AI/NIAID NIH HHS/United States